Workflow
健之佳医药连锁集团股份有限公司2025年第一次临时股东会决议公告

Group 1 - The core point of the announcement is the resolution of the first temporary shareholders' meeting of Jianzhijia Pharmaceutical Chain Group Co., Ltd. held on September 17, 2025, with no rejected resolutions [1][2] - The meeting was convened by the board of directors and chaired by Chairman Lan Bo, complying with the Company Law and the company's articles of association [2][3] - The attendance included 6 out of 7 current directors, all 3 supervisors, and the board secretary, with the general manager and deputy general manager present as well [3] Group 2 - A key resolution passed was the cancellation of the supervisory board, the establishment of employee directors, and the amendment of the company's articles of association [4] - The resolution was approved with more than two-thirds of the voting rights held by shareholders present at the meeting [4] - The legal witness for the meeting was provided by Beijing Deheng (Kunming) Law Firm, confirming that the meeting's procedures and resolutions were lawful and valid [5]